FORM 8K - התקבלה הודעה על חזרה לעמידה בדרישות הרישום של נאסד"ק בקשר עם הון עצמי
false
פלורי אינק
2
380
PLURI INC
Corporation no:
C12337-2001
16338
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
02/03/2026
www.isa.gov.il
www.tase.co.il
Reference:
2026-02-019123
Time of broadcast:
15:44
15:44
The corporation scheduled the publication of the report to
02/03/2026 16:02
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
FORM 8K - התקבלה הודעה על חזרה לעמידה בדרישות הרישום של נאסד"ק בקשר עם הון עצמי
Pluri_Inc_-_Form_8K_-_March_2_2026_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2026-02-009174
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
06/08/2024
Address:
Matam Park
5
,
Haifa
31905
ISRAEL
,
Tel:
074-7107171
,
Fax:
074-7107172
E-mail address:
Info@Pluristem.Com
Company site:
www.pluristem.com
Previous names of reporting entity:
PLURISTEM THERAPEUTICS INC
Name of the Signatory:
Gal Hagit
Position of Signatory in the reporting corporation:
General Counsel & Corporate Secretary
Name of Employer Company:
Address:
Matam Park
5
,
Haifa
3508409
Telephone:
074-7108600
Facsimile:
074-7107172
E-mail:
legalnotices@pluri-biotech.com
1